Fisher-and-Paykel Healthcare Corporation is a medical instruments & supplies business based in Australia. Fisher-and-Paykel Healthcare Corporation shares (FPH) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Fisher-and-Paykel Healthcare Corporation has a trailing 12-month revenue of around $1.7 billion. If you're looking to buy shares, check out the steps below.
To buy shares listed in Australia such as Fisher-and-Paykel Healthcare Corporation, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose. Then follow these steps.
Our top pick for
Best for beginner
Our top pick for
Education & learning
Our top pick for
Australian stocks
| 52-week range | $18.426 - $25.6155 |
|---|---|
| 50-day moving average | $23.151 |
| 200-day moving average | $21.664 |
| Target price | $22.08 |
| PE ratio | 60 |
| Dividend yield | $0.41 (1.36%) |
| Earnings per share (TTM) | $0.41 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$25.45
| 1 week (2024-04-17) | 3.46% |
|---|---|
| 1 month (2024-03-22) | 5.25% |
| 3 months (2024-01-24) | 14.18% |
| 6 months (2023-10-24) | 32.14% |
| 1 year (2023-04-24) | 0.59% |
|---|---|
| 2 years (2022-04-22) | 25.18% |
| 3 years (2021-04-23) | -21.69% |
| 5 years (2019-04-24) | 69.33% |
Valuing Fisher-and-Paykel Healthcare Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fisher-and-Paykel Healthcare Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Fisher-and-Paykel Healthcare Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 60x. In other words, Fisher-and-Paykel Healthcare Corporation shares trade at around 60x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Fisher-and-Paykel Healthcare Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.4677. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fisher-and-Paykel Healthcare Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Fisher-and-Paykel Healthcare Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $438.4 million (£0.0 million).
The EBITDA is a measure of a Fisher-and-Paykel Healthcare Corporation's overall financial performance and is widely used to measure stock profitability.
| Revenue TTM | $1.7 billion |
|---|---|
| Operating margin TTM | 18.99% |
| Gross profit TTM | $938.4 million |
| Return on assets TTM | 9.98% |
| Return on equity TTM | 16.2% |
| Profit margin | 15.45% |
| Book value | 3.01 |
| Market capitalisation | $14.3 billion |
TTM: trailing 12 months
Dividend payout ratio: 1.84% of net profits
Recently Fisher-and-Paykel Healthcare Corporation has paid out, on average, around 1.84% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.36% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Fisher-and-Paykel Healthcare Corporation shareholders could enjoy a 1.36% return on their shares, in the form of dividend payments. In Fisher-and-Paykel Healthcare Corporation's case, that would currently equate to about A$0.41 per share.
While Fisher-and-Paykel Healthcare Corporation's payout ratio might seem low, this can signify that Fisher-and-Paykel Healthcare Corporation is investing more in its future growth.
The latest dividend was paid out to all shareholders who bought their shares by 4 December 2023 (the "ex-dividend date").
Fisher-and-Paykel Healthcare Corporation's shares were split on a 5:1 basis on 26 September 2004. So if you had owned 1 share the day before the split, the next day you would own 5 shares. This wouldn't directly have changed the overall worth of your Fisher-and-Paykel Healthcare Corporation shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Fisher-and-Paykel Healthcare Corporation shares which in turn could have impacted Fisher-and-Paykel Healthcare Corporation's share price.
Over the last 12 months, Fisher-and-Paykel Healthcare Corporation's shares have ranged in value from as little as $18.426 up to $25.6155. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Fisher-and-Paykel Healthcare Corporation's is 0.412. This would suggest that Fisher-and-Paykel Healthcare Corporation's shares are less volatile than average (for this exchange).
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
AMP Ltd Preferred
AUD104.55
ANZ Group Holdings Ltd. Pfd.
AUD101.63
ANZ Group Holdings Ltd. Pfd.
AUD103.35
Challenger Ltd Preferred
AUD106.46
Macquarie Group Ltd Pref C
AUD102.80
Macquarie Group Ltd Pref
AUD105.50
Macquarie Group Limited
AUD105.62
Suncorp Group Ltd Pref
AUD100.61
Westpac Banking Corp Pref
AUD102.76
Everything we know about the Sun Silver IPO, plus information on how to buy in.
Everything we know about the Tasmea Limited IPO, plus information on how to buy in.
Steps to owning and managing Far Northern Resources shares.
Commodity ETFs can be used to hedge against inflation. Here's what they do, why they should be on your watchlist and how they can help your portfolio.
Looking for the best performing stocks in Australia? We update this list weekly.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Trade ASX stocks and ETFs with a $2 brokerage fee and a low minimum investment of just $10.
These ETFs have the lowest fees on the market, but does that make them the best?
You've heard of CommSec but how does it stack up to the likes of IG, CMC Invest and other players in the market?
Westpac Share Trading allows you to take control of your investments. Find out if its right for you.